164 related articles for article (PubMed ID: 7489565)
41. Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy.
Fakhrai H; Dorigo O; Shawler DL; Lin H; Mercola D; Black KL; Royston I; Sobol RE
Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2909-14. PubMed ID: 8610141
[TBL] [Abstract][Full Text] [Related]
42. The effect of the JE (MCP-1) gene, which encodes monocyte chemoattractant protein-1, on the growth of HeLa cells and derived somatic-cell hybrids in nude mice.
Kleine K; König G; Kreuzer J; Komitowski D; Zur Hausen H; Rösl F
Mol Carcinog; 1995 Nov; 14(3):179-89. PubMed ID: 7576110
[TBL] [Abstract][Full Text] [Related]
43. Generation of cytotoxic immune responses against a rat glioma by in vivo priming and secondary in vitro stimulation with tumor cells.
Holladay FP; Lopez G; De M; Morantz RA; Wood GW
Neurosurgery; 1992 Apr; 30(4):499-504; discussion 504-5. PubMed ID: 1584347
[TBL] [Abstract][Full Text] [Related]
44. Synergy of gene-mediated immunoprophylaxis and microbeam radiation therapy for advanced intracerebral rat 9L gliosarcomas.
Smilowitz HM; Blattmann H; Bräuer-Krisch E; Bravin A; Di Michiel M; Gebbers JO; Hanson AL; Lyubimova N; Slatkin DN; Stepanek J; Laissue JA
J Neurooncol; 2006 Jun; 78(2):135-43. PubMed ID: 16598429
[TBL] [Abstract][Full Text] [Related]
45. Recombinant adenovirus-transduced dendritic cell immunization in a murine model of central nervous system tumor.
Broder H; Anderson A; Odesa SK; Kremen TJ; Liau LM
Neurosurg Focus; 2000 Dec; 9(6):e6. PubMed ID: 16817689
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of particulate systems supporting tumor cell fractions in a preventive vaccination against intracranial rat glioma.
Sapin A; Clavreul A; Garcion E; Benoit JP; Menei P
J Neurosurg; 2006 Nov; 105(5):745-52. PubMed ID: 17121138
[TBL] [Abstract][Full Text] [Related]
47. Effects of IFN-gamma and interleukin-1beta on major histocompatibility complex antigen and intercellular adhesion molecule-1 expression by 9L gliosarcoma: relevance to its cytolysis by alloreactive cytotoxic T lymphocytes.
Schiltz PM; Gomez GG; Read SB; Kulprathipanja NV; Kruse CA
J Interferon Cytokine Res; 2002 Dec; 22(12):1209-16. PubMed ID: 12581494
[TBL] [Abstract][Full Text] [Related]
48. The human leukemic T-cell line, TALL-104, is cytotoxic to human malignant brain tumors and traffics through brain tissue: implications for local adoptive immunotherapy.
Kruse CA; Visonneau S; Kleinschmidt-DeMasters BK; Gup CJ; Gomez GG; Paul DB; Santoli D
Cancer Res; 2000 Oct; 60(20):5731-9. PubMed ID: 11059767
[TBL] [Abstract][Full Text] [Related]
49. Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knockout mice for alpha1,3galactosyltransferase.
LaTemple DC; Abrams JT; Zhang SY; Galili U
Cancer Res; 1999 Jul; 59(14):3417-23. PubMed ID: 10416604
[TBL] [Abstract][Full Text] [Related]
50. Interleukin-12-mediated induction of systemic immunity in the periphery and recruitment of activated T cells into the brain produce limited antitumor effects compared with interleukin-2.
Iwadate Y; Namba H; Sakiyama S; Yamaura A; Tagawa M
Int J Mol Med; 2002 Dec; 10(6):741-7. PubMed ID: 12430001
[TBL] [Abstract][Full Text] [Related]
51. Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo.
Laterra J; Nam M; Rosen E; Rao JS; Lamszus K; Goldberg ID; Johnston P
Lab Invest; 1997 Apr; 76(4):565-77. PubMed ID: 9111517
[TBL] [Abstract][Full Text] [Related]
52. In vivo transfer of the human interleukin-2 gene: negative tumoricidal results in experimental brain tumors.
Ram Z; Walbridge S; Heiss JD; Culver KW; Blaese RM; Oldfield EH
J Neurosurg; 1994 Mar; 80(3):535-40. PubMed ID: 8113867
[TBL] [Abstract][Full Text] [Related]
53. Selective radiosensitization of 9L glioma in the brain transduced with double suicide fusion gene.
Kim JH; Kolozsvary A; Rogulski K; Khil MS; Brown SL; Freytag SO
Cancer J Sci Am; 1998; 4(6):364-9. PubMed ID: 9853135
[TBL] [Abstract][Full Text] [Related]
54. Irradiated tumor cells adenovirally engineered to secrete granulocyte/macrophage-colony-stimulating factor establish antitumor immunity and eliminate pre-existing tumors in syngeneic mice.
Nagai E; Ogawa T; Kielian T; Ikubo A; Suzuki T
Cancer Immunol Immunother; 1998 Oct; 47(2):72-80. PubMed ID: 9769115
[TBL] [Abstract][Full Text] [Related]
55. Purified herpes simplex thymidine kinase retroviral particles. II. Influence of clinical parameters and bystander killing mechanisms.
Kruse CA; Lamb C; Hogan S; Smiley WR; Kleinschmidt-Demasters BK; Burrows FJ
Cancer Gene Ther; 2000 Jan; 7(1):118-27. PubMed ID: 10678364
[TBL] [Abstract][Full Text] [Related]
56. Neutron capture therapy of the 9L rat gliosarcoma using the p-boronophenylalanine-fructose complex.
Coderre JA; Button TM; Micca PL; Fisher CD; Nawrocky MM; Liu HB
Int J Radiat Oncol Biol Phys; 1994 Oct; 30(3):643-52. PubMed ID: 7928496
[TBL] [Abstract][Full Text] [Related]
57. Therapeutic efficacy of antitumor dendritic cell vaccinations correlates with persistent Th1 responses, high intratumor CD8+ T cell recruitment and low relative regulatory T cell infiltration.
Driessens G; Gordower L; Nuttin L; Stordeur P; Blocklet D; Egrise D; Velu T; Bruyns C
Cancer Immunol Immunother; 2008 Dec; 57(12):1745-56. PubMed ID: 18369621
[TBL] [Abstract][Full Text] [Related]
58. HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma.
Moriuchi S; Krisky DM; Marconi PC; Tamura M; Shimizu K; Yoshimine T; Cohen JB; Glorioso JC
Gene Ther; 2000 Sep; 7(17):1483-90. PubMed ID: 11001368
[TBL] [Abstract][Full Text] [Related]
59. A 9L gliosarcoma transplantation model for studying adoptive immunotherapy into the brains of conscious rats.
Fleshner M; Watkins LR; Redd JM; Kruse CA; Bellgrau D
Cell Transplant; 1992; 1(4):307-12. PubMed ID: 1344303
[TBL] [Abstract][Full Text] [Related]
60. Bystander effect-mediated therapy of experimental brain tumor by genetically engineered tumor cells.
Namba H; Tagawa M; Iwadate Y; Kimura M; Sueyoshi K; Sakiyama S
Hum Gene Ther; 1998 Jan; 9(1):5-11. PubMed ID: 9458237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
